Mahsa Sedighi

Dr. Mahsa Sedighi


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in International Wound Journal
Verified
Journal Article
Open access
MAMohammad Afshar
Mohammad Afshar
ARAlireza Rezaei
Alireza Rezaei
SESamira Eghbali
Samira Eghbali
SNSamira Nasirizadeh
Samira Nasirizadeh
EAEffat Alemzadeh
Effat Alemzadeh
MSMahsa Sedighi
Mahsa Sedighi
Wound healing is a complex process that orchestrates the coordinated action of various cells, cytokines and growth factors. Nanotechnology offers exciting new possibilities for enhancing the healing process by providing novel materials and approaches to deliver bioactive molecules to the wound site. This article elucidates recent advancements in utilizing nanoparticles, nanofibres and nanosheets for wound healing. It comprehensively discusses the advantages and limitations of each of these materials, as well as their potential applications in various types of wounds. Each of these materials, despite sharing common properties, can exhibit distinct practical characteristics that render them particularly valuable for healing various types of wounds. In this review, our primary focus is to provide a comprehensive overview of the current state‐of‐the‐art in applying nanoparticles, nanofibres, nanosheets and their combinations to wound healing, serving as a valuable resource to guide researchers in their appropriate utilization of these nanomaterials in wound‐healing research. Further studies are necessary to gain insight into the application of this type of nanomaterials in clinical settings.

1 June 2025 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
FNFatemeh Nikoomanesh
Fatemeh Nikoomanesh
MSMahsa Sedighi
Mahsa Sedighi
MBMahdi Mahmmoodi Bourang
Mahdi Mahmmoodi Bourang
MRMitra Rafiee
Mitra Rafiee
André Luis SantosAndré Luis Santos
André Luis Santos
MRMaryam Roudbary
Maryam Roudbary
The incidence of fungal infections is significantly rising, posing a challenge due to the limited class of antifungal drugs. There is a necessity to combat emerging resistant fungal infections by developing novel antifungal agents. This study aimed to evaluate the antifungal effects of lawsone (LAW), a natural component extracted from herbal medicine, and LAW-loaded mesoporous silica nanoparticles (LAW-MSNs) on growth, biofilm formation, and expression of ALS1 and EPA1 genes contributing to cell adhesion of Candida spp. Twenty C. albicans and twenty C. glabrata isolates, including ten fluconazole-resistant and ten fluconazole-susceptible isolates, were examined. The findings of the study indicated that LAW and LAW-MSNs inhibited Candida isolates growth at MIC range of 0.31–>5 µg/mL and significantly reduced biofilm formation in C. albicans and C. glabrata. Moreover, both LAW and LAW-MSNs downregulated the expression of the adhesion genes ALS1 and EPA1 in C. albicans and C. glabrata. Based on the obtained findings, LAW emerged as a promising antifungal candidate. However, the nano-formulation (LAW-MSNs) improved its antifungal properties.